stage III basal cell carcinoma of the lip
Showing 1 - 25 of >10,000
Caregiver, Malignant Head and Neck Tumor, Paranasal Sinus Squamous Cell Carcinoma Trial in Winston-Salem (Communication
Completed
- Caregiver
- +37 more
- Communication Intervention
- +5 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Dec 14, 2022
Papillary Renal Cell Carcinoma Trial (Pembrolizumab, Placebo)
Not yet recruiting
- Papillary Renal Cell Carcinoma
- Pembrolizumab
- Placebo
- (no location specified)
Nov 24, 2023
Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Verrucous Carcinoma of the Oral Cavity, Stage IVA
Withdrawn
- Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity
- +6 more
- hypofractionated radiation therapy
- +3 more
-
New Brunswick, New Jersey
- +1 more
Sep 27, 2022
Cancer, Melanoma Stage III, Melanoma Stage IV Trial (KB707)
Not yet recruiting
- Cancer
- +6 more
- KB707
- (no location specified)
Jul 24, 2023
Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Squamous
Recruiting
- Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
- +50 more
- transoral robotic surgery
- quality of life assessment
-
Columbus, OhioOhio State University Medical Center
Oct 28, 2022
Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer AJCC v8
Not yet recruiting
- Oral Cavity Squamous Cell Carcinoma
- +4 more
- Near Infrared Imaging
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 5, 2022
Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV
Recruiting
- Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +28 more
- Cisplatin
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Dec 16, 2022
Head and Neck Carcinoma of Unknown Primary, Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced
Recruiting
- Head and Neck Carcinoma of Unknown Primary
- +24 more
- Cisplatin
- +2 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Aug 6, 2022
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma Trial
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- +14 more
- Biospecimen Collection
- +9 more
- (no location specified)
Oct 10, 2023
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous
Active, not recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +20 more
- Ipilimumab
- +3 more
-
Tampa, Florida
- +6 more
Jan 13, 2023
NSCLC Trial in Beijing
Recruiting
- NSCLC
-
Beijing, ChinaYuyan Wang
Oct 10, 2023
NSCLC Trial in Changsha (Sugemalimab and Chemotherapy)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- Sugemalimab and Chemotherapy
-
Changsha, ChinaHunan Cancer Hospital
Jul 7, 2023
Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma Stage III
Not yet recruiting
- Squamous Cell Carcinoma of Head and Neck
- +11 more
- KEYTRUDA®
- (no location specified)
Nov 17, 2023
Advanced Head and Neck Squamous Cell Carcinoma, Advanced Hypopharyngeal Squamous Cell Carcinoma, Advanced Laryngeal Squamous
Suspended
- Advanced Head and Neck Squamous Cell Carcinoma
- +17 more
- Intensity-Modulated Radiation Therapy
- Peposertib
-
Gilbert, Arizona
- +19 more
Dec 31, 2022
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous
Not yet recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +12 more
- Biopsy
- +8 more
- (no location specified)
Jun 8, 2023
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,
Recruiting
- Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +24 more
- Carboplatin
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
May 18, 2022
Omitting Clinical Target Volume in Radical Treatment of
Not yet recruiting
- Immunotherapy
- +3 more
- IMRT+adjuvant immunotherapy
- (no location specified)
Jun 9, 2023
Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage II, Nonsmall Cell Lung Cancer Stage III Trial in Tampa (Genomically
Recruiting
- Nonsmall Cell Lung Cancer
- +3 more
- Genomically Guided Radiation Therapy (RT)
-
Tampa, FloridaMoffitt Cancer Center
May 23, 2023
Stage III NSCLC Trial (Toripalimab, JS004, Pemetrexed)
Not yet recruiting
- Stage III Non-small Cell Lung Cancer
- Toripalimab
- +5 more
- (no location specified)
Jun 3, 2023
Merkel Cell Carcinoma Trial in Wollstonecraft (Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination)
Not yet recruiting
- Merkel Cell Carcinoma
- Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination
-
Wollstonecraft, New South Wales, AustraliaMelanoma Institute Australia
Nov 21, 2023
Cutaneous Melanoma, Stage III, Cutaneous Melanoma, Stage IV, Merkel Cell Carcinoma Trial (IFx-Hu2.0)
Available
- Cutaneous Melanoma, Stage III
- +3 more
- IFx-Hu2.0
- (no location specified)
Aug 5, 2022
Stage III NSCLC, Surgery Trial in Guangzhou (Lorlatinib)
Not yet recruiting
- Stage III NSCLC
- Surgery
-
Guangzhou, Guangdong, ChinaGuangdong Provincial People's Hospital
Feb 21, 2023
Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer, Stage II Lung Cancer Trial in Nashville (drug, biological,
Not yet recruiting
- Limited Stage Lung Small Cell Carcinoma
- +3 more
- Cisplatin
- +8 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Nov 10, 2023
Merkel Cell Carcinoma, Merkel Cell Carcinoma, Stage I, Merkel Cell Carcinoma, Stage II Trial in Australia (Avelumab, Placebo)
Recruiting
- Merkel Cell Carcinoma
- +5 more
- Avelumab
- Placebo
-
Port Macquarie, New South Wales, Australia
- +17 more
Aug 30, 2022